Article Details

Pfizer gets US FDA approval for PANZYGA to treat chronic inflammatory demyelinating ...

Retrieved on: 2021-02-13 05:03:45

Tags for this article:

Click the tags to see associated articles and topics

Pfizer gets US FDA approval for PANZYGA to treat chronic inflammatory demyelinating .... View article details on hiswai:

Excerpt

Pfizer announced that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ...

Article found on: www.expresspharma.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo